Hemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary Bypass
Runtime: 20 min
Leading US hospitals1 are implementing PR platelets to ensure platelet availability and safety across a broad spectrum of pathogens. Doctor Marianne Nellis of Cornell shares study findings that assess PR platelet hemostatic efficacy via bleeding in pediatric patients.
Marianne E. Nellis, MD, MS
Division of Pediatric Critical Care Medicine
Department of Pediatrics
Weill Cornell Medicine
- U.S. News & World Report Hospital Rankings & Ratings, 2020-2021, https://health.usnews.com/besthospitals